CHA Biotech Co. Ltd Working Capital to Net Assets Ratio
CHA Biotech Co. Ltd working capital to net assets ratio. CHA Biotech Co. Ltd (085660) has a Working Capital to Net Assets ratio of -12.0% as of June 2026. Working capital of ₩-123.27 Billion (current assets of ₩964.49 Billion minus current liabilities of ₩1.09 Trillion) is measured against net assets of ₩1.03 Trillion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of CHA Biotech Co. Ltd (2014–2025)
Working capital to net assets ratio of CHA Biotech Co. Ltd from 2014 to 2025. This chart shows how CHA Biotech Co. Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at -12.0%, reflecting working capital of ₩-123.27 Billion against net assets of ₩1.03 Trillion KRW. Explore investment intensity of CHA Biotech Co. Ltd to see how much of total assets are deployed in long-term investments.
CHA Biotech Co. Ltd Working Capital to Net Assets Ratio by Year (2014–2025)
CHA Biotech Co. Ltd working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for CHA Biotech Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CHA Biotech Co. Ltd (085660) total assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -53.8% | ₩-435.05 Billion | ₩809.25 Billion | ₩888.14 Billion | ₩1.32 Trillion | ▲ +47.0 pp |
| 2024 | -100.7% | ₩-286.82 Billion | ₩284.69 Billion | ₩733.84 Billion | ₩1.02 Trillion | ▼ -84.3 pp |
| 2023 | -16.4% | ₩-107.95 Billion | ₩656.33 Billion | ₩538.22 Billion | ₩646.17 Billion | ▼ -31.0 pp |
| 2022 | 14.6% | ₩42.52 Billion | ₩291.73 Billion | ₩520.27 Billion | ₩477.75 Billion | ▼ -19.5 pp |
| 2021 | 34.1% | ₩155.38 Billion | ₩456.06 Billion | ₩576.92 Billion | ₩421.54 Billion | ▼ -45.4 pp |
| 2020 | 79.5% | ₩282.30 Billion | ₩355.09 Billion | ₩567.98 Billion | ₩285.68 Billion | ▲ +1.8 pp |
| 2019 | 77.7% | ₩293.24 Billion | ₩377.18 Billion | ₩509.15 Billion | ₩215.91 Billion | ▲ +5.7 pp |
| 2018 | 72.1% | ₩235.62 Billion | ₩326.99 Billion | ₩463.56 Billion | ₩227.94 Billion | ▼ -33.0 pp |
| 2017 | 105.1% | ₩242.46 Billion | ₩230.74 Billion | ₩471.70 Billion | ₩229.25 Billion | ▼ -13.7 pp |
| 2016 | 118.7% | ₩339.98 Billion | ₩286.32 Billion | ₩463.01 Billion | ₩123.03 Billion | ▲ +31.0 pp |
| 2015 | 87.8% | ₩254.58 Billion | ₩290.10 Billion | ₩370.10 Billion | ₩115.52 Billion | ▲ +28.7 pp |
| 2014 | 59.0% | ₩258.22 Billion | ₩437.45 Billion | ₩357.96 Billion | ₩99.74 Billion | — |